SIRT5-dependent desuccinylation licenses UBR5-mediated degradation of TAMM41 to regulate mitochondrial metabolism in lung adenocarcinoma

Haoyang Yuan, Wenxuan Hu, Xin Lv, Yonghao Cao, Kang Hu, Yongsen Li, Zhike Chen, Jian Yang, Yin Wang, Jun Zhao, Chun Xu · 2026

Read SIRT5-dependent desuccinylation licenses UBR5-mediated degradation of TAMM41 to regulate mitochondrial metabolism in lung adenocarcinoma by Haoyang Yuan, Wenxuan Hu, Xin Lv, Yonghao Cao, Kang Hu, Yongsen Li, Zhike Chen, Jian Yang, Yin Wang, Jun Zhao, Chun Xu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13418777.txt.

Introduction

Haoyang Yuan and colleagues traced a mitochondrial control chain in lung adenocarcinoma in 2026, centering on an enzyme, TAMM41, that builds a key membrane fat. TAMM41 ran high in tumors and tracked with poor outlook, yet its role in cancer growth was undefined.

Experiments showed TAMM41 sustains energy production and curbs cell death, while a desuccinylase, SIRT5, marks it for destruction by the ligase UBR5, and removing TAMM41 shrank mouse tumors. The paper nominates TAMM41 as a drug target where mitochondrial metabolism drives lung cancer for teams seeking metabolic targets in current practice.

Catalog record

CREATORHaoyang Yuan, Wenxuan Hu, Xin Lv, Yonghao Cao, Kang Hu, Yongsen Li, Zhike Chen, Jian Yang, Yin Wang, Jun Zhao, Chun Xu
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE57 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13418777

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

SIRT5-dependent desuccinylation licenses UBR5-mediated degradation of TAMM41 to regulate mitochondrial metabolism in lung adenocarcinoma Authors: Haoyang Yuan, Wenxuan Hu, Xin Lv, Yonghao Cao, Kang Hu, Yongsen Li, Zhike Chen, Jian Yang, Yin Wang, Jun Zhao, Chun Xu Published: 2026 ABSTRACT Mitochondrial metabolic reprogramming is essential for lung adenocarcinoma (LUAD) progression, yet the regulatory mechanisms governing mitochondrial phospholipid synthesis remain poorly understood. TAMM41 is a mitochondrial inner-membrane enzyme required for cardiolipin biosynthesis, but its role in LUAD has not been defined. Here, we show that TAMM41 is significantly upregulated in LUAD tissues and cell lines, and its high expression correlates with poor patient prognosis. Functional studies demonstrate that TAMM41 promotes LUAD cell proliferation, migration, and invasion, whereas genetic ablation of TAMM41 suppresses malignant phenotypes. Mechanistically, TAMM41 maintains mitochondrial complex I activity, ATP production, and redox homeostasis, thereby limiting oxidative stress and apoptosis. We identify the E3 ubiquitin ligase UBR5 as a specific regulator of TAMM41 stability through ubiquitination at lysine 206. Moreover, the mitochondrial desuccinylase SIRT5 directly interacts with TAMM41 and removes succinylation at lysine 45, enhancing UBR5 binding and promoting TAMM41 degradation. In vivo, TAMM41 knockout markedly inhibits LUAD xenograft growth, accompanied by impaired mitochondrial respiration and increased apoptosis. Collectively, these findings identify TAMM41 as a mitochondrial oncogenic driver in LUAD and reveal a SIRT5–TAMM41–UBR5 axis that links lysine succinylation to mitochondrial metabolic control, highlighting TAMM41 as a potential therapeutic target. Supplementary InformationThe online version contains supplementary material available at 10.1186/s13062-026-00832-1. Introduction Lung cancer is the leading cause of cancer-related deaths worldwide, with persistently high incidence and mortality rates [1]. Among all malignant tumors, lung cancer not only has the highest incidence rate but also the lowest overall survival rate. Global cancer statistics for 2020 show that lung cancer accounts for approximately 11.4% of all new cancer cases and causes 18.0% of cancer-related deaths. The occurrence of lung cancer is closely related to a variety of risk factors, including smoking, air pollution, occupational exposure, ionizing radiation, gene mutations, and a history of chronic lung infections, making it a major public health problem urgently needing global attention [2]. Lung cancer originates from the bronchial mucosal epithelial cells and is mainly divided into non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) based on histopathological characteristics. NSCLC is the most common pathological type of lung cancer, accounting for approximately 85% of all lung cancer cases, with lung adenocarcinoma (LUAD) being the most prevalent subtype [3]. Early-stage LUAD primarily relies on surgical resection, but once it progresses to an advanced stage, the prognosis remains unfavorable. Currently, the standard treatment strategy for advanced LUAD includes a combination of chemotherapy, radiotherapy, and immunotherapy; however, most patients inevitably develop drug resistance during treatment [4]. This clinical dilemma highlights the urgent need to identify new prognostic biomarkers and systematically elucidate the molecular mechanisms of LUAD to promote the development of more precise and effective targeted therapies. Mitochondria are highly dynamic organelles with significant metabolic activity and are widely regarded as key hubs integrating biosynthesis, bioenergetics, and signal transduction functions. Recent studies from human samples and mouse models have consistently demonstrated that mitochondrial metabolism is highly active during tumor growth and plays an indispensable role in tumorigenesis and maintenance. Mitochondrial metabolism not only provides essential metabolic intermediates for macromolecule synthesis but also supports the anabolic needs of tumor cells by generating various helper metabolites, thereby maintaining their malignant phenotype [5–8]. Cardiolipin (CL) is a unique and crucial phospholipid component of mitochondria, playing a central role in maintaining the structural integrity of the inner mitochondrial membrane, regulating oxidative phosphorylation, and inducing apoptosis [9]. Initial synthesis of CL occurs on the matrix side of the inner mitochondrial membrane. Its precursor, phosphatidic acid (PA), can be synthesized by various enzymes located in the endoplasmic reticulum or outer mitochondrial membrane, and may also be partially derived from the catalytic action of glycerol kinase in the inner membrane. PA from the endoplasmic reticulum is transported across the mitochondrial intermembrane space via the TP53-regulated apoptosis inhibitor protein-evolutionary and lymphocyte-associated domain complex (TRIAP1–PRELID1), and binds to cytidine triphosphate (CTP). Under the catalysis of the mitochondrial-associated protein TAMM41, it is converted into CDP-diacylglycerol (CDP-DAG) [10, 11]. As the initiating enzyme of the CL synthesis pathway, TAMM41 plays a crucial role in maintaining mitochondrial phospholipid homeostasis; however, its expression characteristics and biological functions in lung adenocarcinoma have not been systematically elucidated. This study aims to investigate the role of TAMM41 in LUAD and its potential molecular mechanisms, providing new theoretical basis for a deeper understanding of the role of mitochondrial metabolic reprogramming in lung adenocarcinoma. Materials and methods Clinical specimens Lung adenocarcinoma (LUAD) tissue and its corresponding adjacent non-tumor tissue were collected from patients who underwent surgical resection at the First Affiliated Hospital of Soochow University. All patients had not received chemotherapy or radiotherapy prior to surgery. After surgical resection, tissue specimens were immediately rapidly frozen in liquid nitrogen and stored at −80 °C for subsequent analysis. All patients signed written informed consent forms before sample collection. Specimen collection and use complied with the Declaration of Helsinki. This study protocol was approved by the Ethics Committee of the First Affiliated Hospital of Soochow University. Cell culture Immortalized normal lung epithelial cell line BEAS-2B and lung adenocarcinoma cell lines H1650, A549, PC-9, and H1299 were obtained from the Department of Thoracic Surgery, First Affiliated Hospital of Soochow University. 293T cells were purchased from Novoprotein (Shanghai, China, catalog number: XCK07). All cells underwent routine quality control, including mycoplasma and microbial contamination detection, short tandem repeat (STR) identification, and morphological evaluation. Cells were cultured in a 37 °C, 5% CO₂ incubator. Reagents and antibodies Cell culture reagents used in this study, including fetal bovine serum, matrix gel, culture medium, rotenone, antimycin A, and antibiotics, were all purchased from Thermo Fisher Scientific. Anti-TAMM41 antibody was purchased from Abcam (Cambridge, UK). Other antibodies were generously provided by Dr. Wang and Dr. Xu [12, 13]. Polybrene and other chemical reagents were purchased from Sigma-Aldrich (St. Louis, MO, USA). The usage of fluorescent dyes has been reported in previous studies [14, 15]. Pre-stained protein markers were purchased from APExBIO (Houston, USA, catalog number: F4005). Apoptosis flow cytometry kits, Caspase-3 activity assay kits, and mitochondrial complex I activity assay kits were purchased from Beyotime Biotechnology (China) or GenScript Corporation. Trypsin-EDTA digestion buffer (FL20011) was purchased from Bioland Biotechnology (Hangzhou, China). JC-1 staining Cells were seeded at 1 × 104 cells/well in 24-well plates and cultured for 48 h. JC-1 dye was then added and incubated for 2 h. Mitochondrial membrane depolarization was assessed by detecting the fluorescence intensity of the JC-1 green monomer. A representative image is a combined image of green fluorescence (490 nm) and red fluorescence (625 nm). Co-immunoprecipitation (Co-IP) Cells were cultured to an appropriate density in 10 cm culture dishes and then lysed on ice with pre-chilled IP lysis buffer. The lysis buffer was incubated with the corresponding antibody and Protein A/G agarose beads at 4 °C for 3 h. The cells were then washed three times with pre-chilled IP buffer, and the resulting immunoprecipitate was used for Western blotting or mass spectrometry analysis. Western blotting Cell or tissue samples were lysed on ice, collected with a scraper, and

Read the complete text